Impact of high dose statin trials on hospital prescribers

Author： Barron Thomas   Bennett Kathleen   Feely John  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.63, Iss.1, 2007-01, pp. : 65-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High Density Lipoprotein Cholesterol and Statin Trials

By  

Current Medicinal Chemistry, Vol. 15, Iss. 22, 2008-09 ,pp. : 2265-2270

Bentham Science Publishers

Access to resources Recommend Favorite

Myalgia in Patients on High‐Dose and Low‐to‐Moderate Dose Statin Therapy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 3, 2009-09 ,pp. : 202-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Influence of Hospital-Based Prescribers on Prescribing in General Practice

By Feely J.  

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 175-181

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Candidate Mechanisms for Regression of Coronary Atherosclerosis with High-Dose Statins: Insight from Intravascular Ultrasonography Trials

By Sipahi Ilke   Tuzcu E. Murat  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 6, 2008-01 ,pp. : 365-371

Adis International

Access to resources Recommend Favorite